BioPharma
18 August, 2026 | Tuesday | News
JW Pharmaceutical’s Epaminurad Shows Statistical Superiority in Phase III Gout Trial
-JW Pharmaceutical (KRX:001060) announced that the multinational Phase 3 clinical trial of its gout treatment candidate ‘Epaminurad (code name URC102)’ demonstrated excellent serum uric acid-lo...
Lab
13 August, 2026 | Thursday | News
Thermo Fisher, Michael J. Fox Foundation Expand Parkinson’s Proteomics Resource with 5,500 Samples
Olink™ Explore HT analysis of approximately 5,500 research samples completed, with data now available Key Facts Collaboration: Thermo Fisher Scientific and The Michael J. Fox Foundation expanded ...
BioTech
18 August, 2026 | Tuesday | Analysis
6 Radiopharmaceutical Programmes and Sites to Watch in APAC
Radioligand therapy is the one modality a region cannot buy its way into late. A vial of lutetium-177 loses half its therapeutic activity in roughly six and a half days. A vial of lead-212 loses half in under e...
Contract Services
19 August, 2026 | Wednesday | News
Piramal Pharma Acquires Majority Stake in Yapan Bio to Strengthen Biologics CDMO Capabilities
Yapan Bio Private Limited specializes in process development, characterization, and phase I and II GMP manufacturing services for vaccines and biologics. Piramal has held a stake in Yapan Bio since 2021, ena...
Consumer Health
10 August, 2026 | Monday | Opinion
Why Asia Pacific Must Rethink Chronic Care Before the Demographic Tipping Point
Asia Pacific’s ageing economies are entering a more demanding phase of healthcare planning. As populations live longer, the challenge for healthcare systems is no longer only about extending life expectan...
Medtech
19 August, 2026 | Wednesday | News
Intuitive to Establish 316,000-Sq-Ft Robotic Surgery Manufacturing Facility in Penang
New 316,000-square-foot facility is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032 Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pio...
Cell & Gene
18 August, 2026 | Tuesday | News
AbelZeta Secures US FDA IND Clearance for Bispecific CAR-T Therapy C-CAR039 in Large B-cell Lymphoma
AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, tod...
White Paper
18 August, 2026 | Tuesday | Analysis
6 Radiopharmaceutical Programmes and Sites to Watch in APAC
Product Spot Light
30 July, 2026 | Thursday | News
Eppendorf to Invest EUR 40 Million in New Penang Manufacturing Facility
Premium Article
18 August, 2026 | Tuesday | Analysis
6 Radiopharmaceutical Programmes and Sites to Watch in APAC
Bio Invest
13 August, 2026 | Thursday | News
Ommo Technologies Raises Series A to Scale Spatial Intelligence Platform for Physical AI
Biopharma APAC Infomercial
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
